Debbie van Baarle

2.0k citations

47 papers · 1.3k indexed · h-index 21

Immunology top 5%
Epidemiology top 5%
Oncology top 10%
Virology top 2%
Infectious Diseases top 5%

Co-authors: Erwan Piriou Can Keşmir Frank Miedema Jaap Jan Boelens Nening M. Nanlohy Judy Lieberman Radiana Trifonova Ilka Hoof
Topics: Immune Cell Function and Interaction (17 papers)HIV Research and Treatment (14 papers)T-cell and B-cell Immunology (12 papers)
Cited by: Virology Immunology Hepatology
Journals: Blood The Journal of Immunology PLoS ONE
Partner nations: Netherlands Ethiopia United Kingdom

In The Last Decade

Debbie van Baarle

44 papers receiving 1.3k citations

Peers

Countries citing papers authored by Debbie van Baarle

Since Specialization

Citations

This map shows the geographic impact of Debbie van Baarle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debbie van Baarle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debbie van Baarle more than expected).

Fields of papers citing papers by Debbie van Baarle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debbie van Baarle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debbie van Baarle. The network helps show where Debbie van Baarle may publish in the future.

Co-authorship network of co-authors of Debbie van Baarle

This figure shows the co-authorship network connecting the top 25 collaborators of Debbie van Baarle. A scholar is included among the top collaborators of Debbie van Baarle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debbie van Baarle. Debbie van Baarle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Profiling the fecal microbiome and its modulators across the lifespan in the Netherlands 2024 ·Cell Reports ·(unknown),Jolanda Kool,Roan Pijnacker,Quinten R. Ducarmon,Georg Zeller,Sudarshan A. Shetty,(unknown),(unknown),Fiona van der Klis,Eelco Franz,Lapo Mughini‐Gras,Debbie van Baarle,Susana Fuentes	2
2	Predictive factors for vaccine failure to guide vaccination in allogeneic hematopoietic stem cell transplant recipients 2021 ·Bone Marrow Transplantation ·(unknown),Anke H. W. Bruns,Frans M. Verduyn Lunel,(unknown),(unknown),Nening M. Nanlohy,Gaby Smits,Debbie van Baarle,Jürgen Kuball	5
3	Preventing infectious diseases for healthy ageing: The VITAL public-private partnership project 2020 ·Vaccine ·Debbie van Baarle,Kaatje Bollaerts,Giuseppe Del Giudice,Stephen Lockhart,Christine Luxemburger,Maarten J. Postma,Aura Timen,Baudouin Standaert	18
4	Negative Effect of Age, but Not of Latent Cytomegalovirus Infection on the Antibody Response to a Novel Influenza Vaccine Strain in Healthy Adults 2018 ·Frontiers in Immunology ·(unknown),Albert Wong,(unknown),Ronald Jacobi,Debbie van Baarle,Josine van Beek	28
5	CD4/CD8 ratio is a promising candidate for non-invasive measurement of liver fibrosis in chronic HCV-monoinfected patients 2014 ·European Journal of Clinical Microbiology & Infectious Diseases ·Thijs Feuth,Debbie van Baarle,Karel J. van Erpecum,Peter D. Siersema,Andy I. M. Hoepelman,Joop E. Arends	9
6	Activation of extrinsic apoptosis pathway in HCV monoinfected and HIV–HCV coinfected patients, irrespective of liver disease severity 2014 ·APOPTOSIS ·Thijs Feuth,Debbie van Baarle,Andy I. M. Hoepelman,Karel J. van Erpecum,Peter D. Siersema,Joop E. Arends	6
7	Complementarity of Binding Motifs is a General Property of HLA-A and HLA-B Molecules and Does Not Seem to Effect HLA Haplotype Composition 2013 ·Frontiers in Immunology ·(unknown),Rob J. de Boer,Debbie van Baarle,Martin Maiers,Can Keşmir	3
8	Virologic and immunologic outcome of HAART in Human Immunodeficiency Virus (HIV)-1 infected patients with and without tuberculosis (TB) and latent TB infection (LTBI) in Addis Ababa, Ethiopia 2013 ·AIDS Research and Therapy ·Desta Kassa,(unknown),(unknown),Dawit Wolday,Tsehaynesh Messele,Debbie van Baarle	19
9	HLA class I allele promiscuity revisited 2011 ·Immunogenetics ·(unknown),Ilka Hoof,(unknown),Debbie van Baarle,Can Keşmir	43
10	Immunological Analysis of Treatment Interruption After Early Highly Active Antiretroviral Therapy 2010 ·Viral Immunology ·Ingrid M. M. Schellens,Katalin Pogány,Geertje H. A. Westerlaken,José A. M. Borghans,Frank Miedema,Irene G. M. van Valkengoed,Frank P. Kroon,Joep M. A. Lange,Kees Brinkman,Jan M. Prins,Debbie van Baarle	1
11	T-cell responses at baseline and during therapy with peginterferon-α and ribavirin are not associated with outcome in chronic hepatitis C infected patients 2010 ·Antiviral Research ·Joop E. Arends,Mark A. A. Claassen,Charlotte H. S. B. van den Berg,Nening M. Nanlohy,Karel J. van Erpecum,Bert C. Baak,Andy I. M. Hoepelman,André Boonstra,Debbie van Baarle	4
12	A Comparative Study of HLA Binding Affinity and Ligand Diversity: Implications for Generating Immunodominant CD8+ T Cell Responses 2009 ·The Journal of Immunology ·(unknown),(unknown),Debbie van Baarle,Can Keşmir	42
13	HLA-B molecules target more conserved regions of the HIV-1 proteome 2009 ·AIDS ·(unknown),(unknown),(unknown),Debbie van Baarle,Can Keşmir	12
14	Rituximab Treatment before Reduced-Intensity Conditioning Transplantation Associates with a Decreased Incidence of Extensive Chronic GVHD 2009 ·Biology of Blood and Marrow Transplantation ·Suzanne van Dorp,(unknown),Matthias Wölfl,Leo F. Verdonck,Eefke Petersen,Henk M. Lokhorst,Edwin P. Martens,Matthias Theobald,Debbie van Baarle,Ellen Meijer,Jürgen Kuball	29
15	HIV-1 Can Persist in Aged Memory CD4+ T Lymphocytes With Minimal Signs of Evolution After 8.3 Years of Effective Highly Active Antiretroviral Therapy 2009 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Hans S.L.M. Nottet,Sabine J. van Dijk,Ewout Fanoy,(unknown),Dorien de Jong,Nienke Vrisekoop,Debbie van Baarle,Valerie F. Boltz,Sarah Palmer,Jan C.C. Borleffs,Charles A. Boucher	23
16	Immune surveillance of EBV-infected B cells and the development of non-Hodgkin lymphomas in immunocompromised patients 2008 ·Leukemia & lymphoma ·(unknown),Erwan Piriou,Debbie van Baarle	61
17	Abundance of Early Functional HIV-Specific CD8+ T Cells Does Not Predict AIDS-Free Survival Time 2008 ·PLoS ONE ·Ingrid M. M. Schellens,José A. M. Borghans,Christine A. Jansen,Iris M. De Cuyper,Ronald B. Geskus,Debbie van Baarle,Frank Miedema	24
18	CTL escape and increased viremia irrespective of HIV-specific CD4+ T-helper responses in two HIV-infected individuals 2005 ·Virology ·(unknown),Christine A. Jansen,Elly Baan,Iris M. De Cuyper,(unknown),Hanneke Schuitemaker,Jaap Goudsmit,Georgios Pollakis,Frank Miedema,William A. Paxton,Debbie van Baarle	20
19	Enhancement of human papilloma virus type 16 E7 specific T cell responses by local invasive procedures in patients with (pre)malignant cervical neoplasia 2005 ·International Journal of Cancer ·Jeroen Visser,Debbie van Baarle,(unknown),(unknown),Harry Klip,Ed Schuuring,Esther R. Nijhuis,Michael Pawlita,Laura Bungener,Jacqueline de Vries‐Idema,Hans W. Nijman,Frank Miedema,Toos Daemen,Ate G.J. van der Zee	15
20	High Prevalence of Epstein‐Barr Virus Type 2 among Homosexual Men Is Caused by Sexual Transmission 2000 ·The Journal of Infectious Diseases ·Debbie van Baarle,Egbert Hovenkamp,Nicole H. T. M. Dukers–Muijrers,Neil Renwick,Marie José Kersten,Jaap Goudsmit,Roel A. Coutinho,Frank Miedema,Marinus H. J. van Oers	41

About Debbie van Baarle

Debbie van Baarle is a scholar working on Virology, Immunology and Hepatology, having authored 47 papers that have together received 1.3k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (17 papers), HIV Research and Treatment (14 papers) and T-cell and B-cell Immunology (12 papers). The work is most often cited by research in Virology (304 citations), Immunology (644 citations) and Hepatology (158 citations). Debbie van Baarle has collaborated with scholars based in Netherlands, Ethiopia and United Kingdom. Frequent co-authors include Erwan Piriou, Can Keşmir, Frank Miedema, Jaap Jan Boelens, Nening M. Nanlohy, Judy Lieberman, Radiana Trifonova, Ilka Hoof, Frank Miedema and Elisabeth A. M. Sanders. Their work appears in journals such as Blood, The Journal of Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact